Our findings showed that CSNK1D was a poor prognostic factor in GBM, KICK, KIRC, LIHC, and PRAD, while it acted as a protective factor in MESO and PAAD (Figure 2A). Here, CSNK1D is linked to pancreatic adenocarcinoma.